Home

Paul W. Hoelscher

CIK 1611468 · EVP, CFO · last filed 2026-06-15

Paul W. Hoelscher is an EVP, CFO who has filed 42 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for SGMT, was dated Jun 15, 2026. Across all open-market trades the lifetime net is −$62.9M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

42

Lifetime Open-Market Net

-$62.93M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SGMT Director — $7.27 — $0 4 2026-06-15
OnKure Therapeutics, Inc. (RPHM) Delisted Director — $18.20 — $0 3 2023-06-08
Horizon Therapeutics Public Ltd Co (HZNP) Delisted EVP, CFO 89,264 $116.30 $10.38M -$62.93M 35 2022-04-22

Recent Filings

42 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-15 SGMT Grant (A) — $0 EDGAR
2025-06-10 SGMT Grant (A) — $0 EDGAR
2024-06-07 SGMT Grant (A) — $0 EDGAR
2024-04-03 SGMT Grant (A) — $0 EDGAR
2023-06-08 OnKure Therapeutics, Inc. (RPHM) Delisted Grant (A) — $0 EDGAR
2022-06-03 OnKure Therapeutics, Inc. (RPHM) Delisted Grant (A) — $0 EDGAR
2022-04-22 Horizon Therapeutics Public Ltd Co (HZNP) Delisted Mixed — -$4.63M EDGAR
2022-04-08 Horizon Therapeutics Public Ltd Co (HZNP) Delisted Mixed −91,710 -$29.20M EDGAR
2022-03-25 Horizon Therapeutics Public Ltd Co (HZNP) Delisted Mixed −13,843 -$3.98M EDGAR
2022-01-24 Horizon Therapeutics Public Ltd Co (HZNP) Delisted Mixed +3,095 -$212.9K EDGAR
Showing 1–10 of 42
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.